ESMAFLUX LSR

ESMAFLUX LSR is a potent gastroprotective medication specifically designed to provide relief from acid-related gastrointestinal disorders such as heartburn, acid reflux, gastritis, and gastroesophageal reflux disease (GERD). It contains Esomeprazole, a proton pump inhibitor (PPI), which effectively reduces the production of gastric acid, offering both immediate and long-term relief from acidity-related discomfort.

The formulation works by selectively inhibiting the proton pumps in the stomach lining, which are responsible for secreting hydrochloric acid. By suppressing acid production, ESMAFLUX LSR helps heal esophageal irritation, prevent ulcer formation, and reduce symptoms such as burning sensation, sour belching, regurgitation, and upper abdominal pain. Its targeted action ensures that patients experience significant relief while protecting the gastrointestinal mucosa from further damage.

ESMAFLUX LSR is recommended for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and peptic ulcer-related conditions. It is also suitable for patients who experience frequent acidity due to stress, irregular eating patterns, excessive spicy or oily food intake, or prolonged use of NSAIDs.

Regular use under medical supervision not only alleviates immediate symptoms but also promotes healing of the stomach and esophagus, reducing the risk of recurrence and improving overall digestive comfort. Patients often notice enhanced appetite, reduced bloating, and improved digestion after consistent therapy.

The medicine is well-tolerated, safe, and effective when administered as prescribed. Its long-acting acid suppression mechanism ensures that patients receive sustained relief, making it suitable for both acute and chronic acid-related conditions.

With its fast-acting acid suppression, mucosal protection, and symptom relief, ESMAFLUX LSR is a trusted solution for managing gastric acidity and reflux, supporting long-term gastrointestinal health and overall well-being.